Barinthus Biotherapeutics Ratios (2020-2025) | BRNS

Ratios Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
EBT Margin -659.43%-848.53%-73.73%-3,464.41%-4,102.33%-48,128.57%-29,136.84%1,668,600.00%11.39%86.59%122.42%-359.02%-4,004.06%-7,473.05%-54.33%-6,227.85%-2,115,100.00%
EBIT Margin -659.43%-848.53%-43.92%-2,721.19%-2,870.70%-48,128.57%-29,136.84%1,666,800.00%4.35%77.57%117.37%-388.62%-4,590.60%-7,885.33%-62.66%-6,518.99%-2,332,400.00%
EBITDA Margin -659.43%-848.53%-43.92%-2,721.19%-2,870.70%-48,128.57%-29,136.84%1,666,800.00%4.35%77.57%117.37%-388.62%-2,915.17%-5,455.09%7.13%-4,750.63%-1,283,600.00%
Operating Margin -659.43%-848.53%-43.92%-2,721.19%-2,870.70%-48,128.57%-29,136.84%1,666,800.00%4.35%77.57%117.37%-388.62%-4,590.60%-7,885.33%-62.66%-6,518.99%-2,332,400.00%
Net Margin -659.43%-848.53%-73.73%-3,464.41%-4,072.09%-48,162.86%-29,100.00%1,683,700.00%17.14%91.95%133.35%-327.75%-3,893.80%-7,132.93%-54.31%-6,220.89%-2,112,600.00%
FCF Margin -616.03%-474.76%16.58%-1,438.14%-3,888.84%-42,360.00%-11,294.74%839,600.00%-52.90%-59.63%153.74%-184.75%-1,213.89%-5,982.04%-122.33%-4,717.41%-1,814,100.00%
Efficiency
Assets Average 108.58M213.16M258.20M268.64M283.42M285.59M280.27M272.84M266.01M253.97M238.05M222.24M206.99M193.12M187.72M174.51M151.16M135.78M119.38M
Equity Average -44.87M98.54M246.19M247.52M252.85M253.95M249.46M243.68M238.38M225.52M206.53M191.30M179.51M164.40M158.13M144.80M122.86M109.04M93.52M
Invested Capital -36.91M-52.83M249.91M242.47M252.72M253.14M254.77M244.15M243.20M233.57M217.46M195.60M187.00M172.02M156.79M159.46M130.13M115.59M102.48M84.56M
Asset Utilization Ratio 0.040.020.000.000.050.110.140.160.110.050.030.000.000.080.090.100.110.00
Leverage & Solvency
Interest Coverage Ratio -1.47-3.66-2.33-926.008.84-0.00M-0.00M-0.00M-0.00M-0.00M-551.76-0.00M-0.00M-0.00M-0.00M
Debt to Equity 0.00
Debt Ratio 0.00
Equity Ratio -0.73-0.320.960.950.900.880.890.890.900.890.880.850.870.860.840.850.810.810.790.77
Times Interest Earned -1.47-3.66-2.33-926.008.84-0.00M-0.00M-0.00M-0.00M-0.00M-551.76-0.00M-0.00M-0.00M-0.00M
Valuation
Enterprise Value -42.88M-155.66M-243.10M-233.38M-213.62M-200.20M-191.96M-199.79M-194.08M-191.06M-172.78M-160.10M-141.88M-129.82M-117.63M-105.94M-112.29M-100.48M-87.68M-75.58M
Return Ratios
Return on Sales -6.59%-8.49%-0.74%-34.64%-40.72%-481.63%-291.00%16,837.00%0.17%0.92%1.33%-3.28%-38.94%-71.33%-10.65%-91.58%-211.81%-0.54%-4.09%-62.21%-21,126.00%-239.58%
Return on Capital Employed -0.22%-0.17%-0.15%-0.18%-0.14%-0.03%0.02%-0.02%-0.10%-0.27%-0.41%-0.40%-0.41%-0.40%-0.37%-0.43%-0.51%-0.62%-0.76%
Return on Invested Capital -0.18%-0.15%-0.02%0.02%-0.10%-0.09%-0.27%-0.41%-0.42%-0.43%-0.42%-0.40%-0.47%-0.58%-0.70%-0.88%
Return on Assets -0.26%-0.19%-0.17%-0.18%-0.13%-0.01%0.03%0.02%-0.06%-0.22%-0.32%-0.33%-0.34%-0.33%-0.31%-0.35%-0.43%-0.51%-0.64%
Return on Equity 0.62%-0.41%-0.18%-0.19%-0.14%-0.02%0.04%0.02%-0.06%-0.24%-0.37%-0.38%-0.39%-0.39%-0.37%-0.42%-0.53%-0.64%-0.81%